Drug Delivery, Biosensors
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
39
NCT04707131
A Study of Single Ascending Dose of LEM-S401 in Healthy Participants
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 11, 2022
Completion: Feb 3, 2023
NCT06032000
Evaluation of Safety and Immunogenicity of a SARS-CoV-2(Severe Acute Respiratory Syndrome Coronavirus 2) Booster Vaccine (LEM-mR203)
Start: Nov 6, 2023
Completion: Mar 28, 2025
Loading map...